{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:49:34Z","timestamp":1789951774953,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11899-016-0357-7","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T06:39:41Z","timestamp":1480401581000},"page":"504-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Enteropathy-Associated T-Cell Lymphoma"],"prefix":"10.1007","volume":"11","author":[{"given":"Sarah","family":"Ondrejka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Jagadeesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"357_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118:148\u201355.","journal-title":"Blood"},{"key":"357_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0609.2005.00495.x","volume":"75","author":"M-Y Lee","year":"2005","unstructured":"Lee M-Y, Tsou M-H, Tan T-D, Lu M-C. Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma. Eur J Haematol. 2005;75:221\u20136.","journal-title":"Eur J Haematol"},{"key":"357_CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","volume":"18","author":"J Gale","year":"2000","unstructured":"Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol. 2000;18:795\u2013803.","journal-title":"J Clin Oncol"},{"key":"357_CR4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.23213","volume":"87","author":"E Tse","year":"2012","unstructured":"Tse E et al. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol. 2012;87:663\u20138.","journal-title":"Am J Hematol"},{"key":"357_CR5","unstructured":"Isaacson PG, Chott A, Ott G, Stein H. In World Health Organization classification of tumours of the haematopoietic and lymphoid tissues. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman J, editors. IARC; 2008. p. 289\u201391."},{"key":"357_CR6","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1002\/cncr.26700","volume":"118","author":"RZ Sharaiha","year":"2012","unstructured":"Sharaiha RZ et al. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer. 2012;118:3786\u201392.","journal-title":"Cancer"},{"key":"357_CR7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10620-007-9952-8","volume":"53","author":"M Silano","year":"2008","unstructured":"Silano M, Volta U, DeVincenzi A, Dessi M. D. M. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci. 2008;53:972\u20136.","journal-title":"Dig Dis Sci"},{"key":"357_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-159-3-201308060-00006","volume":"159","author":"B Lebwohl","year":"2013","unstructured":"Lebwohl B, Granath F, Ekbom A, Smedby KE, Murray JA, Neugut AI, et al. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease. Ann Intern Med. 2013;159:169\u201375.","journal-title":"Ann Intern Med"},{"key":"357_CR9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","volume":"35","author":"JKC Chan","year":"2011","unstructured":"Chan JKC et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression. Am J Surg Pathol. 2011;35:1557\u201369.","journal-title":"Am J Surg Pathol"},{"key":"357_CR10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2011.45","volume":"24","author":"J Sun","year":"2011","unstructured":"Sun J, Lu Z, Yang D, Chen J. Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol. 2011;24:983\u201392.","journal-title":"Mod Pathol"},{"key":"357_CR11","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","volume":"27","author":"S-Y Tan","year":"2013","unstructured":"Tan S-Y et al. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8\u03b1\u03b1 phenotype. Leukemia. 2013;27:1688\u201396.","journal-title":"Leukemia"},{"key":"357_CR12","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","volume":"132","author":"RJ Deleeuw","year":"2007","unstructured":"Deleeuw RJ et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007;132:1902\u201311.","journal-title":"Gastroenterology"},{"key":"357_CR13","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/PAS.0000000000000295","volume":"38","author":"SH Swerdlow","year":"2014","unstructured":"Swerdlow SH et al. Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol. 2014;38:e60\u201371.","journal-title":"Am J Surg Pathol"},{"key":"357_CR14","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"357_CR15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/003655200750023129","volume":"35","author":"F Biagi","year":"2000","unstructured":"Biagi F, Lorenzini P. C. G. Literature review on the clinical relationship between ulcerative jejunitis, coeliac disease and enteropathy associated T cell lymphoma. Scand J Gastroenterol. 2000;35:785\u201390.","journal-title":"Scand J Gastroenterol"},{"key":"357_CR16","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","volume":"119","author":"AD Sabatino","year":"2012","unstructured":"Sabatino AD, Biagi F, Gobbi PG, C. G. How I treat enteropathy-associated T-cell lymphoma. Blood2. 2012;119:2458\u201368.","journal-title":"Blood2"},{"key":"357_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","volume":"34","author":"G Malamut","year":"2012","unstructured":"Malamut G, Meresse B, Cellier C, Cerf-Bensussan N. Refractory celiac disease: from bench to bedside. Semin Immunopathol. 2012;34:601\u201313.","journal-title":"Semin Immunopathol"},{"key":"357_CR18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ajg.2011.104","volume":"106","author":"B Roshan","year":"2011","unstructured":"Roshan B et al. The incidence and clinical spectrum of refractory celiac disease in a North American referral center. Am J Gastroenterol. 2011;106:923\u20138.","journal-title":"Am J Gastroenterol"},{"key":"357_CR19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136:81\u201390.","journal-title":"Gastroenterology"},{"key":"357_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9343(03)00302-4","volume":"115","author":"PH Green","year":"2003","unstructured":"Green PH et al. Risk of malignancy in patients with celiac disease. Am J Med. 2003;115:191\u20135.","journal-title":"Am J Med"},{"key":"357_CR21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.dld.2011.07.012","volume":"43","author":"O Olen","year":"2011","unstructured":"Olen O et al. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis. 2011;43:862\u20138.","journal-title":"Dig Liver Dis"},{"key":"357_CR22","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","volume":"115","author":"M Sieniawski","year":"2010","unstructured":"Sieniawski M et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood. 2010;115:3664\u201370.","journal-title":"Blood"},{"key":"357_CR23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.clnu.2015.04.014","volume":"35","author":"NJ Wierdsma","year":"2016","unstructured":"Wierdsma NJ et al. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis. Clin Nutr. 2016;35:685\u201391.","journal-title":"Clin Nutr"},{"key":"357_CR24","unstructured":"Muller-Hermelink H, Delabie J, Ko Y, et al. WHO classification of tumours of the digestive system 112\u20134 (IARC, 2010)."},{"key":"357_CR25","doi-asserted-by":"crossref","unstructured":"Ondrejka SL, Moffitt AB, Tse E, Hsi ED, Goodlad JR, au-Yeung R, Kwong Y-L, Srivastava G. Gascoyne R, Rajagopalan D, Love C, Dave S. Whole exome sequencing of type I and type II enteropathy-associated T-cell lymphoma reveals genetic basis of oncogenesis 622 (American Society of Hematology, ASH oral presentation 2015).","DOI":"10.1182\/blood.V126.23.575.575"},{"key":"357_CR26","unstructured":"Howat AJ, McPhie JL, Smith DA, et al. Cavitation of mesenteric lymph nodes: a rare complication of coeliac disease, associated with a poor outcome. Histopathology1 146, 509\u2013519 (995)."},{"key":"357_CR27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","volume":"161","author":"A Zettl","year":"2002","unstructured":"Zettl A, Ott G, Makulik A, Katzenberger T, Starostik P, Eichler T, et al. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol. 2002;161:1635\u201345.","journal-title":"Am J Pathol"},{"key":"357_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.52.2.205","volume":"52","author":"V Verkarre","year":"2003","unstructured":"Verkarre V, Asnafi V, Lecomte T, et al. Refractory celiac disease is a diffuse gastrointestinal disease. Gut. 2003;52:205\u201311.","journal-title":"Gut"},{"key":"357_CR29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1309\/NW2BK1DXB0EQG55H","volume":"127","author":"A Zettl","year":"2007","unstructured":"Zettl A, de Leeuw R, Haralambieva EM-HH. Enteropathy-type T-cell lymphoma. Am J Clin Pathol. 2007;127:701\u20136.","journal-title":"Am J Clin Pathol"},{"key":"357_CR30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.12596","volume":"66","author":"PG Foukas","year":"2015","unstructured":"Foukas PG, de Leval L. Recent advances in intestinal lymphomas. Histopathology. 2015;66:112\u201336.","journal-title":"Histopathology"},{"key":"357_CR31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.5858\/arpa.2013-0242-CR","volume":"137","author":"DP Arps","year":"2013","unstructured":"Arps DP, Smith LB. Classic versus type II enteropathy-associated T-cell lymphoma: diagnostic considerations. Arch Pathol Lab Med. 2013;137:1227\u201331.","journal-title":"Arch Pathol Lab Med"},{"key":"357_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","volume":"45","author":"G Malamut","year":"2013","unstructured":"Malamut G et al. Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis. 2013;45:377\u201384.","journal-title":"Dig Liver Dis"},{"key":"357_CR33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/modpathol.2015.85","volume":"28","author":"S Tomita","year":"2015","unstructured":"Tomita S et al. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod Pathol. 2015;28:1286\u201396.","journal-title":"Mod Pathol"},{"key":"357_CR34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/leu.2010.295","volume":"25","author":"SY Tan","year":"2011","unstructured":"Tan SY, Ooi AS, Ang MK, et al. Nuclear expression of MATK is a novel marker of type II enteropathy associated T-cell lymphoma. Leukemia. 2011;25:555\u20137.","journal-title":"Leukemia"},{"key":"357_CR35","first-page":"1274","volume":"45","author":"K Kikuma","year":"2013","unstructured":"Kikuma K, Yamada K, Nakamura S, Ogami A, et al. Detailed clinicopathologic characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan. Hum Pathol. 2013;45:1274\u201384.","journal-title":"Hum Pathol"},{"key":"357_CR36","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C K\u00fc\u00e7\u00fck","year":"2015","unstructured":"K\u00fc\u00e7\u00fck C et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells. Nat Commun. 2015;6:6025.","journal-title":"Nat Commun"},{"key":"357_CR37","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","volume":"30","author":"M-L Nairism\u00e4gi","year":"2016","unstructured":"Nairism\u00e4gi M-L et al. JAK-STAT and G protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia. 2016;30:1311\u20139.","journal-title":"Leukemia"},{"key":"357_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","volume":"126","author":"G Hapgood","year":"2015","unstructured":"Hapgood G, Savage KJ. The biology and management of systemic anaplastic large cell lymphoma. Blood. 2015;126:17\u201325.","journal-title":"Blood"},{"key":"357_CR39","unstructured":"Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? - PubMed - NCBI. at < http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26319391 >"},{"key":"357_CR40","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","volume":"117","author":"A Mansoor","year":"2011","unstructured":"Mansoor A et al. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 2011;117:1447\u201352.","journal-title":"Blood"},{"issue":"2","key":"357_CR41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.humpath.2013.08.003","volume":"45","author":"V Leventaki","year":"2014","unstructured":"Leventaki V et al. Indolent peripheral T-cell lymphoma involving the gastrointestinal tract. Hum Pathol. 2014;45(2):421\u20136.","journal-title":"Hum Pathol"},{"key":"357_CR42","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","volume":"116","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi K et al. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116:5631\u20137.","journal-title":"Blood"},{"key":"357_CR43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2007-966239","volume":"39","author":"S Daum","year":"2007","unstructured":"Daum S et al. Capsule endoscopy in refractory celiac disease. Endoscopy. 2007;39:455\u20138.","journal-title":"Endoscopy"},{"key":"357_CR44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1572-0241.2007.01122.x","volume":"102","author":"M Hadithi","year":"2007","unstructured":"Hadithi M et al. The value of double-balloon enteroscopy in patients with refractory celiac disease. Am J Gastroenterol. 2007;102:987\u201396.","journal-title":"Am J Gastroenterol"},{"key":"357_CR45","first-page":"1622","volume":"47","author":"M Hadithi","year":"2006","unstructured":"Hadithi M et al. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med. 2006;47:1622\u20137.","journal-title":"J Nucl Med"},{"key":"357_CR46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.52.3.347","volume":"52","author":"M Hoffmann","year":"2003","unstructured":"Hoffmann M et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut. 2003;52:347\u201351.","journal-title":"Gut"},{"key":"357_CR47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiol.11101808","volume":"259","author":"SJB Weyenberg Van","year":"2011","unstructured":"Van Weyenberg SJB et al. MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system. Radiology. 2011;259:151\u201361.","journal-title":"Radiology"},{"key":"357_CR48","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2012-11-466839","volume":"121","author":"E Jantunen","year":"2013","unstructured":"Jantunen E et al. Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT. Blood. 2013;121:2529\u201332.","journal-title":"Blood"},{"key":"357_CR49","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d\u2019Amore","year":"2012","unstructured":"d\u2019Amore F et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30:3093\u20139.","journal-title":"J Clin Oncol"},{"key":"357_CR50","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","volume":"124","author":"F Ellin","year":"2014","unstructured":"Ellin F, Landstr\u00f6m J, Jerkeman M, Relander T. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry. Blood. 2014;124:1570\u20137.","journal-title":"Blood"},{"key":"357_CR51","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjh.13555","volume":"172","author":"PK Karanam","year":"2016","unstructured":"Karanam PK, Al-Hamadani M, Go RS. Enteropathy-associated T-cell lymphoma in the US: higher incidence and poorer survival among Asians. Br J Haematol. 2016;172:990\u20132.","journal-title":"Br J Haematol"},{"key":"357_CR52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cyto.b.20481","volume":"76","author":"WHM Verbeek","year":"2009","unstructured":"Verbeek WHM et al. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom. 2009;76:367\u201374.","journal-title":"Cytometry B Clin Cytom"},{"key":"357_CR53","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1111\/j.1572-0241.2008.02213.x","volume":"103","author":"WHM Verbeek","year":"2008","unstructured":"Verbeek WHM et al. The presence of small intestinal intraepithelial gamma\/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease. Am J Gastroenterol. 2008;103:3152\u20138.","journal-title":"Am J Gastroenterol"},{"key":"357_CR54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","volume":"36","author":"T Pongpruttipan","year":"2012","unstructured":"Pongpruttipan T et al. Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36:481\u201399.","journal-title":"Am J Surg Pathol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-016-0357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-016-0357-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-016-0357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T15:32:26Z","timestamp":1601220746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-016-0357-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1007\/s11899-016-0357-7","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}